The Cochrane group concluded that compared to the long GnRH agonist protocol,GnRH antagonists significantly reduced the incidence of OHSS with no evidence ofa difference in live birth rates (Al-Inanyet al., 2011). Here, GNRH1 is linked to ovarian hyperstimulation syndrome.